A phase 2 multi-center, randomized dose-finding trial of rPA-102 vaccine in healthy adult volunteers

Trial Profile

A phase 2 multi-center, randomized dose-finding trial of rPA-102 vaccine in healthy adult volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2006

At a glance

  • Drugs RPA 102 (Primary)
  • Indications Anthrax
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors VaxGen
  • Most Recent Events

    • 31 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top